Vielight Neuro RX Gamma - Feasibility Pilot

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

November 12, 2021

Study Completion Date

February 28, 2022

Conditions
Alzheimer Disease
Interventions
DEVICE

Neuro RX Gamma synchronous

Twenty minute treatment, six days per week for 12 weeks

DEVICE

Sham

Twenty minutes, six days per week for 12 weeks with sham device

DEVICE

Neuro RX Gamma asynchronous

Twenty minutes, six days per week for 12 weeks with sham device

Trial Locations (1)

M3B2S7

Toronto Memory Program, Toronto

All Listed Sponsors
lead

Vielight Inc.

INDUSTRY

NCT03328195 - Vielight Neuro RX Gamma - Feasibility Pilot | Biotech Hunter | Biotech Hunter